Cargando…

Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy

Compounds that recognize and strongly bind to molecular targets are one of the cornerstones of modern pharmaceutics. Work has been ongoing for the past 25 years on the therapeutic use of aptamers, nucleic acid molecules, whose three-dimensional structure is the result of interactions between complem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurek, Przemysław M, Zabłocki, Konrad, Waśko, Urszula, Mazurek, Maciej P, Otlewski, Jacek, Jeleń, Filip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396944/ https://www.ncbi.nlm.nih.gov/pubmed/28442904 http://dx.doi.org/10.2147/IJN.S125231

Ejemplares similares

Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
por: Pala, Katarzyna, et al.
Publicado: (2013)

Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer
por: Kolovskaya, Olga S., et al.
Publicado: (2020)

Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing Cancers
por: Porębska, Natalia, et al.
Publicado: (2021)

FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation
por: Szlachcic, Anna, et al.
Publicado: (2012)

The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
por: Poźniak, Marta, et al.
Publicado: (2021)

Drug Conjugation via Maleimide–Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies
por: Jendryczko, Karolina, et al.
Publicado: (2022)

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2017)

FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1
por: Jendryczko, Karolina, et al.
Publicado: (2020)

Pseudo-superparamagnetic behaviour of barium hexaferrite particles
por: Dudziak, Szymon, et al.
Publicado: (2020)

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1)
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2020)

Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
por: Silva, André C, et al.
Publicado: (2011)

On the relaxation time of interacting superparamagnetic nanoparticles and implications for magnetic fluid hyperthermia
por: Kuncser, Andrei, et al.
Publicado: (2019)

Superparamagnetic Oxygen-Loaded Nanobubbles to Enhance Tumor Oxygenation During Hyperthermia
por: Zullino, Sara, et al.
Publicado: (2019)

Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2018)

High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1
por: Opaliński, Łukasz, et al.
Publicado: (2018)

Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms
por: Ansari, Shaquib Rahman, et al.
Publicado: (2022)

Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
por: Dias, Alexandre M. M., et al.
Publicado: (2022)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Szymczyk, Jakub, et al.
Publicado: (2021)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
por: Lipok, Magdalena, et al.
Publicado: (2019)

Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity
por: Opaliński, Łukasz, et al.
Publicado: (2017)

Gold-Coated Superparamagnetic Nanoparticles for Single Methyl Discrimination in DNA Aptamers
por: Tintoré, Maria, et al.
Publicado: (2015)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles
por: Kalber, Tammy L, et al.
Publicado: (2016)

The role of dipole interactions in hyperthermia heating colloidal clusters of densely-packed superparamagnetic nanoparticles
por: Fu, Rong, et al.
Publicado: (2018)

Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance
por: Dadfar, Seyed Mohammadali, et al.
Publicado: (2020)

Ultra-high rate of temperature increment from superparamagnetic nanoparticles for highly efficient hyperthermia
por: Lee, Jae-Hyeok, et al.
Publicado: (2021)

Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies
por: Reyes-Ortega, Felisa, et al.
Publicado: (2021)

Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers
por: Borek, Aleksandra, et al.
Publicado: (2018)

Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Jendryczko, Karolina, et al.
Publicado: (2021)

Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
por: Douziech-Eyrolles, Laurence, et al.
Publicado: (2007)

Aptamer loaded superparamagnetic beads for selective capturing and gentle release of activated protein C
por: Hamedani, Nasim Shahidi, et al.
Publicado: (2022)

Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
por: Zukowska, Dominika, et al.
Publicado: (2023)

Designing red-fluorescent superparamagnetic nanoparticles by conjugation with gold clusters
por: Mikalauskaite, Agne, et al.
Publicado: (2022)

Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity
por: Williams, James P, et al.
Publicado: (2013)

Functionalized Hydrophilic Superparamagnetic Iron Oxide Nanoparticles for Magnetic Fluid Hyperthermia Application in Liver Cancer Treatment
por: Kandasamy, Ganeshlenin, et al.
Publicado: (2018)

Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects
por: Deh, Kofi, et al.
Publicado: (2020)

The Hybrid System for the Magnetic Characterization of Superparamagnetic Nanoparticles
por: Midura, Mateusz, et al.
Publicado: (2022)

Rational Design of Aptamer-Tagged tRNAs
por: Mukai, Takahito
Publicado: (2020)

A new paradigm for artesunate anticancer function: considerably enhancing the cytotoxicity via conjugating artesunate with aptamer
por: Li, Yingying, et al.
Publicado: (2021)

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
por: Szymczyk, Jakub, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sndchm6u3omsv4o74f567apohg